India's government on Wednesday (June 16) defended its decision to double the gap between the two doses of the AstraZeneca Covid-19 vaccine to up to 16 weeks, after three advisers said the move was not approved by its national immunisation advisory body. <br /><br />WATCH MORE: https://thestartv.com/c/news<br />SUBSCRIBE: https://cutt.ly/TheStar<br />LIKE: https://fb.com/TheStarOnline
